Nedaplatin: a radiosensitizing agent for patients with cervical cancer.
about
Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors.Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume hUtility of risk-weighted surgical-pathological factors in early-stage cervical cancer.Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinomaDose-volume analysis of predictors for chronic gastrointestinal complications in patients with cervical cancer treated with postoperative concurrent chemotherapy and whole-pelvic radiation therapy.
P2860
Nedaplatin: a radiosensitizing agent for patients with cervical cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Nedaplatin: a radiosensitizing agent for patients with cervical cancer.
@ast
Nedaplatin: a radiosensitizing agent for patients with cervical cancer.
@en
type
label
Nedaplatin: a radiosensitizing agent for patients with cervical cancer.
@ast
Nedaplatin: a radiosensitizing agent for patients with cervical cancer.
@en
prefLabel
Nedaplatin: a radiosensitizing agent for patients with cervical cancer.
@ast
Nedaplatin: a radiosensitizing agent for patients with cervical cancer.
@en
P2860
P356
P1476
Nedaplatin: a radiosensitizing agent for patients with cervical cancer.
@en
P2093
Seiji Mabuchi
Tadashi Kimura
P2860
P304
P356
10.1155/2011/963159
P577
2010-09-21T00:00:00Z